DeepRhythmAI vs iPredict Eye Screening
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
DeepRhythmAI is a specialized tool for detailed cardiac arrhythmia detection and classification from ECG data, catering specifically to cardiology. In contrast, iPredict Eye Screening primarily focuses on AI-powered screening for retinal diseases like AMD, DR, and Glaucoma. While iPredict also offers risk prediction for systemic diseases including heart attack, DeepRhythmAI is designed for in-depth cardiac rhythm diagnostics, making them suitable for different clinical needs.
Choose DeepRhythmAI if…
Choose DeepRhythmAI if your primary need is highly accurate and efficient AI-powered detection and classification of complex cardiac arrhythmias from ECG data. This tool is ideal for cardiology practices and health systems aiming to significantly reduce missed diagnoses and streamline high-volume ECG analysis workflows.
View DeepRhythmAI →Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if you require a broad, easy-to-operate AI-powered screening solution for early detection of multiple retinal diseases (AMD, DR, Glaucoma) and systemic disease risk prediction. It is best suited for primary care settings or telemedicine services seeking quick, non-invasive screening that integrates with EHRs.
View iPredict Eye Screening →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | DeepRhythmAI | iPredict Eye Screening |
|---|---|---|
| Pricing | Contact vendor for pricing information | Contact for pricing |
| Deployment | Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | DeepRhythmAI | iPredict Eye Screening |
|---|---|---|
| Primary Clinical Focus | Cardiac arrhythmia detection and classification from ECG data. | Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), Glaucoma; risk prediction for systemic diseases (stroke, heart attack). |
| Target Healthcare Settings | Solo to large health systems | Primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| Core AI Functionality | AI-powered arrhythmia detection and classification utilizing CNN and Transformer models. | AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma; AI-Based Telemedicine Service; Online Health Risk Prediction System. |
| API Availability | Yes | Not specified |
| Data Export Capability | Yes | Not specified |
| Reported Accuracy/Impact | Reduces missed diagnoses (14x to 114x fewer). | Approximately 95% on average (AMD sensitivity 86.86%, specificity 94.13%). |
| Speed of Analysis | Faster ECG reporting and analysis. | Test completed in less than 5 minutes, report in under 60 seconds. |
Videos
Demos, reviews, and walkthroughs featuring DeepRhythmAI and iPredict Eye Screening.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
DeepRhythmAI offers an API for seamless integration with existing medical devices and EMR systems, aiming to streamline ECG reporting and analysis and potentially increase efficiency by up to 65%. iPredict Eye Screening explicitly provides EHR solutions and a telemedicine service, designed for accessibility in various clinical settings, offering fast results in under 5 minutes with reports in under 60 seconds.
DeepRhythmAI demonstrates superior accuracy in cardiac arrhythmia detection, with studies showing a 14 to 114 times lower risk of missed diagnoses compared to technician analysis, and a negative predictive value of 99.9% for critical arrhythmias. iPredict Eye Screening reports high accuracy, approximately 95% on average, with AMD sensitivity at 86.86% and specificity at 94.13% for early detection of retinal diseases.
DeepRhythmAI is specifically designed for Cardiology, revolutionizing cardiac arrhythmia detection and classification from ECG data, addressing challenges like the global shortage of ECG technicians and increasing patient wait times. iPredict Eye Screening serves Family Medicine, Internal Medicine, and Ophthalmology by providing AI-powered screening for Diabetic Retinopathy, Age-related Macular Degeneration, Glaucoma, and risk prediction for systemic diseases like stroke and heart attack.
While DeepRhythmAI emphasizes streamlining clinical workflows and offers an intuitive user interface through its DeepRhythm Platform, suggesting a focus on user-friendliness. iPredict Eye Screening explicitly highlights its 'easy to operate' system with an 'advanced touchscreen interface' and minimal training requirements (less than 1-2 hours), indicating a short learning curve for quick adoption.
DeepRhythmAI aims for faster ECG reporting and analysis, promising up to a 65% increase in workflow efficiency, indicating rapid time-to-value. iPredict Eye Screening delivers rapid results, with tests completed in less than 5 minutes and fully automated reports generated in under 60 seconds, suggesting immediate operational efficiency gains.
DeepRhythmAI is designed for scalability, targeting solo to large health systems and is utilized by numerous healthcare providers globally, with its cloud-based nature and API availability contributing to its accessibility across various settings. iPredict Eye Screening is accessible in primary care settings, clinics, hospitals, and online for telemedicine, indicating flexibility for broad deployment and large-scale screening across various locations.